Raia Drogasil S.A.
RADLY | OTC
$2.88
+$0.14 (+5.11%)
Nov 2, 2026, 11:01 AM ET · Market open
+5.11%
(1D)No price chart data available for 1D timeframe.
Rating
50.1
+0.6 ptsFundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #277/1028 (Top 27%)
Key Statistics
Market Data
Market Cap $5.04B
1D Range
2.77 2.89
52W Range
2.76 5.28
Valuation (TTM)
PE 18.94
PB 3.42
EV/EBITDA 6.69
Valuation (NTM)
Forward PE 13.34
Forward PEG 1.14
Price Target $0.00
Cash Flow
FCF Yield 6.2%
SBC Adj. FCF Yield 6.1%
SBC Impact -1.2%
Margins
Gross Margin 27.6%
Operating Margin 6.5%
FCF Margin 3.6%
Growth (CAGR)
Revenue 3Y | 5Y 12.4% |
15.3%
Dil EPS 3Y | 5Y 8.1% |
11.8%
FCF 3Y | 5Y 22.6% |
10.6%
Returns
ROA 5.3%
ROE 18.6%
ROIC 15.7%
Financial Health
Net Debt
R$2.8B ($541.63M)
Current Ratio 1.41
Interest Coverage 2.55
Dividends
Div Yield 3.26%
Payout Ratio 11.3%
FCF Payout Ratio 36.3%
Loading financial charts...
Profile
Raia Drogasil SA engages in the retail sale of medicine, perfumery, personal care and beauty products, cosmetics and dermocosmetics. Its stores are supplied by distribution centers located in the stat...
Sector Healthcare
Industry Medical - Pharmaceuticals
Employees 73,895
IPO Date Jul 19, 2016
Website rdsaude.com.br
Fiscal Year n/a
Latest News
3 months ago · seekingalpha.com
Raia Drogasil S.A. (RADLY) Q2 2026 Earnings Call TranscriptRaia Drogasil S.A. (RADLY) Q2 2026 Earnings Call Transcript
Add to Watchlist
Select watchlists to add or remove RADLY